Skip to main content
Erschienen in: Gut Pathogens 1/2018

Open Access 01.12.2018 | Genome Report

Genome analyses of blaNDM-4 carrying ST 315 Escherichia coli isolate from sewage water of one of the Indian hospitals

verfasst von: Ayesha Z. Beg, Asad U. Khan

Erschienen in: Gut Pathogens | Ausgabe 1/2018

Abstract

Background

Emergence of carbapenem resistant Escherichia coli pathovars and their environmental dissemination are alarming problems. E. coli isolated from sewage water of hospital setting conferred a high resistance towards β-lactams, particularly towards carbapenem. This prompted us to perform whole genome sequence analysis to investigate the antimicrobial determinants, pathogenicity status and mobile genetic elements associated with resistance genes.

Results

To the best of our knowledge this is the first report of ST 315 carrying NDM-4 from India. The genome analysis has revealed the unknown characteristics associated with this sequence type (ST 315) like resistance and virulence factors. Based on virulence markers, its pathotype was identified as ExPEC. Furthermore, a mobile plasmid with multiple β-lactamases genes and clinically relevant resistance markers was detected. Phylogenetic analysis of Inc F plasmids sequences carrying ESBLs and NDM variants, revealed un-relatedness in these plasmids due to their varying size and backbone sequences.

Conclusions

Presence of carbapenem resistant E. coli ST 315 with high level antibiotic resistance, near hospital environment is an alarming situation in context to its spread. WGS based analyses have provided details on virulence and resistance status which could overcome the lack of information available on ST 315, globally. This could further help in its quick detection and control in clinical settings.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s13099-018-0247-8) contains supplementary material, which is available to authorized users.

Background

Escherichia coli share a commensal relationship with humans and animals. The extensive acquisition of virulence genes has potentiated E. coli to become pathogenic [1]. The E. coli pathotypes are identified on the basis of virulence determinants present in the genome. A pathotype, ExPEC (extra intestinal pathogenic E. coli) has been reported in extra intestinal, neonatal meningitis and septicaemia infections. Over the years ExPECs are being increasingly recognised for plasmid-mediated carriage of extended spectrum β-lactamases and carbapenemases (metallo β-lactamases, MBLs) [2]. The emergence of a carbapenemase, New Delhi-Metallo β-lactamase (NDM-1) has conferred resistance to last resort β-lactams which has further made the management of ExPECs difficult [3]. A single amino acid variation (Met154Leu) in NDM-1 has resulted in the emergence of a novel NDM-4 which has extended and increased hydrolytic activity towards β-lactams, especially towards carbapenem [4].
The bacterial isolate AK-1 found in hospital sewage water was subjected to antibiotic susceptibility testing which revealed an exorbitantly elevated MIC values against β-lactams [5]. This unusual resistance in AK-1 strain intrigued us to further explore other genetically predisposed features through whole genome sequencing.

Materials and methods

E. coli isolation and characterisation

The isolate for whole genome sequence analysis was collected and identified as reported in our previous published study [5]. It was identified and characterised as NDM-4 producing E. coli strain.

Whole genome sequencing, annotation and analysis

The bacterial DNA was isolated from the AK-1 strain by Qiagen’s QIAamp DNA mini kit and GE SimpliNano UV–Vis Spectrophotometer was used to measure the concentration and purity of the DNA. The genomic DNA was subjected to whole genome sequencing on Illumina NextSeq 500 platform using the paired-end 2 × 150 nt sequencing protocol. The raw sequence data was further analysed by FastQC tool for quality control purposes [6]. SPAdes version 3.10.1 was used to create denovo assembly with genome coverage of 266.181× [7]. Genome annotation was performed by NCBI Prokaryotic Genome Annotation Pipeline using Best-placed reference protein set and GeneMarkS+ methodology.
StringMLST tool [8] was used to determine sequence type and multi-locus sequence typing database of E. coli at PubMLST (http://​ukmirror1.​pubmlst.​org/​databases.​shtml) [9] was used as reference. The serotype of the strain (fliC, wxy and wzx genes) was determined by SerotypeFinder [10]. Resistance genes were identified using CARD and ARDB databases [11, 12]. Virulence factors were determined using the combination of UniProt and Virulence finder database (VFDB) [13]. Further genome analyses was done using ISfinder [14] and RAC [15]. Phylogenetic analysis was done on MEGA (version 7) using plasmid sequences retrieved from GenBank.

Quality assurance

Escherichia coli ST 315 genomic DNA was extracted from a single colony and this strain was maintained. The 16s rRNA gene from the draft genome was confirmed to check for contamination. High quality of reads were confirmed by CLC bio Genomic Workbench version 9 (CGWB) and selected for assembly.

Results and discussion

General features

The genome NSBV00000000 E. coli consists of 129 contigs, which equals to 5,076,053 bp in length. The mean G+C content of the genome is 50.74%. Other features are enlisted in Table 1. The serotype analysis of the AK-1 with the aid of fliC, wzy and wzx genes profile was found to be O7: H15. MLST analysis (adk:fumC:gyrB:icd:mdh:purA:recA;4:26:2:25:5:8:19) identified AK-1 as ST 315. AK-1, E. coli ST 315 is included in clonal complex ST38 which is associated with phylogenetic group D and this clonal complex has preference to harbour ESBLs, particularly CTX-M-14 and CTX-M-15 [16]. Ewers et al. described numbers of E. coli ST 315 isolates carrying blaNDM-1 and globally associated with human host [17].
Table 1
General features of AK-1 genome
 Feature
Number
Genes (total)
5271
CDS (total)
5176
Genes (coding)
4948
CDS (coding)
4948
Genes (RNA)
95
rRNAs
6, 2, 5 (5S, 16S, 23S)
Complete rRNAs
6, 1 (5S, 16S)
Partial rRNAs
1, 5 (16S, 23S)
tRNAs
71
ncRNAs
11
Pseudo genes (total)
228
CRISPR arrays
2
AK-1 was found to carry a plasmid of 155,678 bp (Additional file 1: Figure S1). pMLST identified plasmid belonging to IncF group having alleles, repFIB and repFII.

Resistance genes

One of the highlight of this study was an NDM-4 carrying multidrug plasmid. It harboured 15 resistance markers (Additional file 2: Table S1) and some of them were in association with mobile genetic elements (MGEs). Genetic context of the resistance markers on the plasmid was determined to assess their association with mobile genetic elements and their potential for horizontal gene transfer. Genetic environment of blaNDM-1 have revealed the downstream presence of bleMBL and upstream presence of remnants of, or entire ISAba125 [18]. The plasmid pAK1 shared similar arrangement for blaNDM-4 with partial ISAba125 (Fig. 1a).
The genetic environment of blaTEM1b was identified to be flanked by one truncated copy of IS26. The blaTEM1b gene was associated with partial Tn2, it was present distally to tnpR-encoding gene and proximally to an IR (Fig. 1b) [19].
A truncated Tn2 transposon unit was found to be associated with blaCTX-M-15. It was revealed that both DRL and DRR were bracketing this unit where ISEcp1 was distally located to blaCTX-M-15 gene (Fig. 1c). This arrangement is very common and ISEcp1 is reported to mediate the mobilization of blaCTX-M-15 [20, 21].
Other previously reported resistance genes and associated mobile genetic elements were found on AK-1 plasmid. (i) Class I integron carrying qacE∆ 1, sul 2, dfrA12 and aadA2 (Fig. 1d) [22], (ii) rmt B was found to be associated with partial sequence of IS 26 (Fig. 1e) and upstream to blaTEM1b (not shown) [23], (iii) sul1 gene upstream to strA and strB genes which are bracketed by Tn 5903 [24], (iv) tet (A) efflux protein and its regulator tet R (A) associated with Tn1721 mobile element [25].
AK-1 chromosome carries wide range of resistance markers towards major classes of antibiotics like flouroquinoles, macrolides, aminoglycosides, tetracycline, trimethoprim isoniazid, triclosan, elfamycin and β-lactams (Additional file 3: Table S2). Extensive numbers of genes conferring resistance towards β-lactams were found; four types of penicillin binding proteins and class C β-lactamases, blaCFE 1 and blaPEDO 2. Accumulative effect of these genes explains the high level of phenotypic resistance towards β-lactams in AK-1 [5].

Virulence factors of ST 315 E. coli

ST 315 E. coli has been reported earlier in urosepsis, intra-abdominal infections and primary sepsis in medical cases [16]. Therefore, comparative analysis [with NC_017646 (NMEC), NC_008253 (UPEC), NC_017631 (UPEC), NC_007946 (UPEC)] and exploration of virulence genes in AK-1 was performed which resulted in identification of assorted virulence factors. These are commonly associated with ExPEC isolates [26] as shown in Table 2. E. coli type III secretion system 2 (ETT2) identified in AK-1 has been previously reported in E. coli strains in partial or complete form [27]. ETT2 is associated with virulence regulation in some ExPEC strains and pathogenicity in septicemic E. coli [28]. Pathogenicity island (PAI), type 6 secretion system was identified in AK-1 [29]. Multiple PAI, invested in fimbriae and adhesions expression, were observed in AK-1 strain which are described as (i) Type 1 fimbriae is common in UPEC, causes infection in mucous surfaces by inducing adhesion and virulence [30], (ii) Chaperone usher (CU) fimbriae clusters yad and sfm provide additional adhesion to the host [31], (iii) Mat (meningitis associated and temperature regulated) fimbria or E. coli common pilus (ECP) responsible for colonisation and adherence in host [32], (iv) Curli fibres binds to hosts matrix and plasma protein, and is reported to cause haemagglutination, fibronectin binding and formation of proteolytically active plasmin which aids in bacterial diffusion through tissue disintegration [30], (v) ExPEC specific FdeC (factor adherence E. coli) responsible for bacterial fitness and colonization in UTI [33].
Table 2
Virulence genes
Virulence factors
Adhesins/fimbriae
Iron uptake
Toxins
Secretion systems
Protectins/invasins
Type 1 fimbriae NSBV01000003 (15138–21501) sfm fimbriae NSBV01000011 (7740–14015) yad fimbriae NSBV01000005 (66168–72121) MAT(ECP) fimbriae NSBV01000007 (119869–126709) FdeC NSBV01000007 (106372–110622) Curli NSBV01000004 (93069–97942)
ChuA NSBV01000028 (31777–40728) Enterobactin NSBV01000021 (27676–46582) Aerobactin NSBV01000005 (59212–52929)
HlyA NSBV01000011 (54096–55271) HlyE NSBV01000026 (46866–47777)
TypeIII secretion system (ETT2) NSBV01000002 (15607–31153) TypeVI secretion system NSBV01000032 (5165–28659)
ColV NSBV01000002 (84476–84964) ibeB NSBV01000021 (57575–58957) K1capsule NSBV01000002 (150300–158286) ompA NSBV01000004 (166414–167466)
Haemolytic toxins were also identified in AK-1 (i) Hemolysin α is associated with ExPEC virulence and attacks immune cell [34], (ii) membrane pore-forming toxin HlyE lyses mammalian cells and erythrocytes [35].
ExPECs cope up with low iron availability by secreting siderophores which retrieves sequestered iron from host proteins [36]. AK-1 was identified to harbour aerobactin, enterobactin and chuA siderophores. Proectins/invasins like ibeB, ompA and K1 capsule have been reported in invasion of brain microvasular endothelial cells [37].

Phylogenetic analysis of plasmid

Presence of emerging NDM variant along with multidrug resistances on a mobile Inc F plasmid prompted us to compare the pattern of their dissemination and relatedness. Phylogenetic analysis was performed using plasmid sequences which produced significant alignment with AK-1 plasmid, and the query coverage was found between 44 and 53% of all the plasmid sequences with ~ 99% identity. Furthermore, plasmid sequences having alleles, repFIB and/or repFII and acquired genes, blaTEM1 and/or blaCTX-M-15, and/or blaNDM variants (NDM-4/NDM-1/NDM-5), were specifically selected for comparisons with AK-1 plasmid (Fig. 2). The result showed overall dissimilarity in the backbone sequences except for plasmid pGUE NDM (France) which differs by nine single nucleotide variations with AK-1 plasmid. Distribution and backbone sequences of Inc F plasmids harbouring NDM variants and/or ESBLs (CTX-M-15/TEM1b) are inconsistent. Active mobilome could account for such high variation in plasmid sequences. This implies ExPECs carrying such plasmids could have fluctuating resistance profile leading to a concern for clinicians.
The genetic context of NDM-4 in AK-1 plasmid was similar to plasmids (pM109 FII, pMC-NDM, pGUE NDM, pCRKP-2297, pCRKP-1215, pM214 FII, and pNDM5-IBAC) carrying NDM variants. The genetic environment for blaNDM remained conserved in these plasmids. This suggests that alteration in bla gene originated new NDM variants. Furthermore, genetic context of blaTEM1b and blaCTX-M-15 were almost similar in these plasmids.

Conclusions

Presence of plasmid harbouring blaNDM-4 and other β-lactamase genes near the hospital setting environment is a serious concern in context to its circulation and spread in hospital settings. It is the first time NDM-4 producing ST 315 E. coli was detected in India. Moreover, no genome based information on ST 315 strain is yet available. Lack of information on mechanism of virulence, transmission sources and other genetic characteristics have become an impasse for alleviation of ExPECs infections. AK-1 genome based virulence profile provides cause of serious infections by ST 315 ExPEC, a common microflora of healthy individuals. Genome informed virulence and resistance mechanisms will definitely help in identification of this ExPECs in healthcare settings and controlling the clonal spread of carbapenamase carrying E. coli pathovars.

Authors’ contributions

AZB, analysed the data and wrote the first draft of the MS. AUK, provided the NGS data, helped in interpretation of the data and checked first draft. Both authors read and approved the final manuscript.

Acknowledgements

We acknowledge the support of internal funds of Biotechnology Department.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The whole genome sequence project of AK-1 is deposited to GenBank under the accession id NSBV01000000 and consists of sequences NSBV01000001–NSBV01000129. The genome draft has also been published [38].
Not applicable.
Not applicable.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8(1):26–38.CrossRefPubMed Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8(1):26–38.CrossRefPubMed
2.
4.
Zurück zum Zitat Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother. 2012;56(4):2184–6.CrossRefPubMedPubMedCentral Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother. 2012;56(4):2184–6.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Khan AU, Parvez S. Detection of blaNDM-4 in Escherichia coli from hospital sewage. J Med Microbiol. 2014;63(10):1404–6.CrossRefPubMed Khan AU, Parvez S. Detection of blaNDM-4 in Escherichia coli from hospital sewage. J Med Microbiol. 2014;63(10):1404–6.CrossRefPubMed
7.
8.
Zurück zum Zitat Gupta A, Jordan IK, Rishishwar L. stringMLST: a fast k-mer based tool for multilocus sequence typing. Bioinformatics. 2016;33(1):119–21.CrossRefPubMed Gupta A, Jordan IK, Rishishwar L. stringMLST: a fast k-mer based tool for multilocus sequence typing. Bioinformatics. 2016;33(1):119–21.CrossRefPubMed
11.
13.
Zurück zum Zitat Kleinheinz KA, Joensen KG, Larsen MV. Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences. Bacteriophage. 2014;4(2):e27943.CrossRefPubMedPubMedCentral Kleinheinz KA, Joensen KG, Larsen MV. Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences. Bacteriophage. 2014;4(2):e27943.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Siguier P, et al. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(suppl_1):D32–6.CrossRefPubMed Siguier P, et al. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(suppl_1):D32–6.CrossRefPubMed
16.
Zurück zum Zitat Peirano G, et al. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J Clin Microbiol. 2012;50(2):294–9.CrossRefPubMedPubMedCentral Peirano G, et al. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J Clin Microbiol. 2012;50(2):294–9.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Ewers C, et al. Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect. 2012;18(7):646–55.CrossRefPubMed Ewers C, et al. Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect. 2012;18(7):646–55.CrossRefPubMed
19.
Zurück zum Zitat Wang J, et al. Characterization of the genetic environment of blaESBL genes, integrons and toxin-antitoxin systems identified on large transferrable plasmids in multi-drug resistant Escherichia coli. Front Microbiol. 2015;5:716.CrossRefPubMedPubMedCentral Wang J, et al. Characterization of the genetic environment of blaESBL genes, integrons and toxin-antitoxin systems identified on large transferrable plasmids in multi-drug resistant Escherichia coli. Front Microbiol. 2015;5:716.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Boyd DA, et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother. 2004;48(10):3758–64.CrossRefPubMedPubMedCentral Boyd DA, et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother. 2004;48(10):3758–64.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Poirel L, Decousser J-W, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrob Agents Chemother. 2003;47(9):2938–45.CrossRefPubMedPubMedCentral Poirel L, Decousser J-W, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrob Agents Chemother. 2003;47(9):2938–45.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Gillings MR, Paulsen IT, Tetu SG. Genomics and the evolution of antibiotic resistance. Ann N Y Acad Sci. 2016;1388(1):92–107.CrossRefPubMed Gillings MR, Paulsen IT, Tetu SG. Genomics and the evolution of antibiotic resistance. Ann N Y Acad Sci. 2016;1388(1):92–107.CrossRefPubMed
23.
Zurück zum Zitat Yu FY, et al. High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital. BMC Infect Dis. 2010;10(1):184.CrossRefPubMedPubMedCentral Yu FY, et al. High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital. BMC Infect Dis. 2010;10(1):184.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Sundin GW, Bender CL. Dissemination of the strA–strB streptomycin-resistance genes among commensal and pathogenic bacteria from humans, animals, and plants. Mol Ecol. 1996;5(1):133–43.CrossRefPubMed Sundin GW, Bender CL. Dissemination of the strA–strB streptomycin-resistance genes among commensal and pathogenic bacteria from humans, animals, and plants. Mol Ecol. 1996;5(1):133–43.CrossRefPubMed
25.
Zurück zum Zitat Wang W, et al. High-level tetracycline resistance mediated by efflux pumps Tet (A) and Tet (A)-1 with two start codons. J Med Microbiol. 2014;63(11):1454–9.CrossRefPubMed Wang W, et al. High-level tetracycline resistance mediated by efflux pumps Tet (A) and Tet (A)-1 with two start codons. J Med Microbiol. 2014;63(11):1454–9.CrossRefPubMed
26.
Zurück zum Zitat Mellata M. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends. Foodborne Pathog Dis. 2013;10(11):916–32.CrossRefPubMedPubMedCentral Mellata M. Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends. Foodborne Pathog Dis. 2013;10(11):916–32.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Ideses D, et al. A degenerate type III secretion system from septicemic Escherichia coli contributes to pathogenesis. J Bacteriol. 2005;187(23):8164–71.CrossRefPubMedPubMedCentral Ideses D, et al. A degenerate type III secretion system from septicemic Escherichia coli contributes to pathogenesis. J Bacteriol. 2005;187(23):8164–71.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Wang S, et al. Escherichia coli type III secretion system 2 ATPase EivC is involved in the motility and virulence of avian pathogenic Escherichia coli. Front Microbiol. 2016;7:1387.PubMedPubMedCentral Wang S, et al. Escherichia coli type III secretion system 2 ATPase EivC is involved in the motility and virulence of avian pathogenic Escherichia coli. Front Microbiol. 2016;7:1387.PubMedPubMedCentral
29.
Zurück zum Zitat Bingle LEH, Bailey CM, Pallen MJ. Type VI secretion: a beginner’s guide. Curr Opin Microbiol. 2008;11(1):3–8.CrossRefPubMed Bingle LEH, Bailey CM, Pallen MJ. Type VI secretion: a beginner’s guide. Curr Opin Microbiol. 2008;11(1):3–8.CrossRefPubMed
31.
Zurück zum Zitat Badouraly RA, et al. Escherichia coli K-12 possesses multiple cryptic but functional chaperone–usher fimbriae with distinct surface specificities. Environ Microbiol. 2010;12(7):1957–77.CrossRefPubMed Badouraly RA, et al. Escherichia coli K-12 possesses multiple cryptic but functional chaperone–usher fimbriae with distinct surface specificities. Environ Microbiol. 2010;12(7):1957–77.CrossRefPubMed
32.
Zurück zum Zitat Rendon MA, et al. Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci. 2007;104(25):10637–42.CrossRefPubMedPubMedCentral Rendon MA, et al. Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci. 2007;104(25):10637–42.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Nesta B, et al. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio. 2012;3(2):e00010–2.CrossRefPubMedPubMedCentral Nesta B, et al. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio. 2012;3(2):e00010–2.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Thomas S, Holland IB, Schmitt L. The type 1 secretion pathway—the hemolysin system and beyond. Biochim Biophys Acta. 2013;1843(8):1629–41.CrossRefPubMed Thomas S, Holland IB, Schmitt L. The type 1 secretion pathway—the hemolysin system and beyond. Biochim Biophys Acta. 2013;1843(8):1629–41.CrossRefPubMed
35.
Zurück zum Zitat Hunt S, Green J, Artymiuk PJ. Hemolysin E (HlyE, ClyA, SheA) and related toxins. In: Proteins membrane binding and pore formation. 2010:116–26. Hunt S, Green J, Artymiuk PJ. Hemolysin E (HlyE, ClyA, SheA) and related toxins. In: Proteins membrane binding and pore formation. 2010:116–26.
36.
Zurück zum Zitat Garenaux A, Caza M, Dozois CM. The Ins and Outs of siderophore mediated iron uptake by extra-intestinal pathogenic Escherichia coli. Vet Microbiol. 2011;153(1):89–98.CrossRefPubMed Garenaux A, Caza M, Dozois CM. The Ins and Outs of siderophore mediated iron uptake by extra-intestinal pathogenic Escherichia coli. Vet Microbiol. 2011;153(1):89–98.CrossRefPubMed
37.
Zurück zum Zitat Wang S, et al. IbeB is involved in the invasion and pathogenicity of avian pathogenic Escherichia coli. Vet Microbiol. 2012;159(3):411–9.CrossRefPubMed Wang S, et al. IbeB is involved in the invasion and pathogenicity of avian pathogenic Escherichia coli. Vet Microbiol. 2012;159(3):411–9.CrossRefPubMed
38.
Zurück zum Zitat Khan AU, Beg AZ, Verma PK. Draft genome sequence of the first NDM-4-producing Escherichia coli strain (AK1), isolated from sewage water of a North Indian hospital. Genome Announc. 2017;5(50):e01366-17.CrossRefPubMedPubMedCentral Khan AU, Beg AZ, Verma PK. Draft genome sequence of the first NDM-4-producing Escherichia coli strain (AK1), isolated from sewage water of a North Indian hospital. Genome Announc. 2017;5(50):e01366-17.CrossRefPubMedPubMedCentral
Metadaten
Titel
Genome analyses of blaNDM-4 carrying ST 315 Escherichia coli isolate from sewage water of one of the Indian hospitals
verfasst von
Ayesha Z. Beg
Asad U. Khan
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
Gut Pathogens / Ausgabe 1/2018
Elektronische ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-018-0247-8

Weitere Artikel der Ausgabe 1/2018

Gut Pathogens 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.